Abstract
Parenteral emulsions may be utilized to overcome major formulation challenges such as solubilization of poorly aqueous-soluble drugs and/or protection of drugs susceptible to hydrolysis. In addition, they can be used for the purposes of controlled and sustained drug release, drug targeting, and/or reduction of toxic effects to sensitive tissues. Emulsions are thermodynamically unstable and do not form spontaneously; however, emulsion stability can be substantially improved using suitable emulsifiers and viscosity enhancing agents. Drug release rates from emulsion systems are determined by both the carrier and the drug characteristics. It is not an easy task to characterize in vitro drug release from emulsions due to the physical obstacles associated with separation of the dispersed and continuous phases; however, various techniques have been successfully used. This chapter provides an overview of the physicochemical properties, methods of preparation, stability, and application of emulsion formulations.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Marti-Mestres G, Nielloud F (2002) Emulsions in health care; aplications – an overview. J Dispersion Sci Technol 23(1–3):419–439
Becher SE, Schick MJ (1987) Macroemulsions. In: Schick MJ (ed) Surfactant science series, nonionic surfactants – physical chemistry, vol 23. Marcel Dekker, New York, pp 435–491
Friberg SE, Goldsmith LB, Hilton ML (1988) Theory of emulsions. In: Lieberman HA, Rieger MM, Banker GS (eds) Pharmaceutical dosage forms: disperse systems. Marcel Dekker, New York, pp 49–91
Junginger HE (1992) In: Sjoblom J. Emulsions – a fundamental and practical approach, NATO ASI Series, Series C, Kluger (ed.) v. 363, p 189
Collins-Gold LC, Lyons RT, Bartholow LC (1990) Parenteral emulsions for drug delivery. Adv Drug Deliv Rev 5:189–208
Davis SS, Hadgraft J, Palin KJ (1985) Medical and pharmaceutical applications of emulsions. In: Becher P (ed) Encyclopedia of emulsion technology. Dekker, New York, pp 159–238
Klang S, Benita S (1998) Design and evaluation of submicron emulsions as colloidal drug carriers for intravenous administration. In: Benita S (ed) Submicron emulsions in drug targeting and delivery. Harwood Academic Publishers, Amsterdam, pp 127–131
Bruck SD (1983) Controlled drug delivery, basic concepts, vol 1. CRC, Boca Raton, p 187
Chidambaram N, Burgess DJ (2005) Emulsions: design and manufacturing. In: Burgess DJ (ed) Drug and the pharmaceutical sciences – injectable dispersed systems: formulation, processing and performance, vol 149. Taylor & Francis, Boca Raton, pp 213–293
Singh M, Ravin LJ (1986) Parenteral emulsions as drug carrier systems. J Parenteral Sci Tech 40(1):34–41
Benita S, Levy MY (1993) Submicron emulsions as colloidal drug for intravenous administration: comprehensive physicochemical characterization. J Pharm Sci 82(11):1069–1079
Morrison ID, Ross S (2002) Emulsions. colloidal dispersions – suspensions, emulsions and foams. Wiley, New York, pp 420–455
Sznitowska M, Janicki S, Dabrowska E, Zurowska-Pyczkowska K (2001) Submicron emulsions as drug carriers: Studies on destabilization potential of various drugs. Eur J Pharm Sci 12:175–179
Tamilvanan S (2004) Oil-in-water lipid emulsions: implications for parenteral and ocular delivering systems. Prog Lipid Res 43:489–533
Hora M, Tuck S (2000) Emulsions for sustained drug delivery. In: Senior J, Radomsky M (eds) Sustained release injectable products. Interpharm, Denver, pp 109–136
Capek I (2004) Degradation of kinetically-stable o/w emulsions. Adv Colloid Interface Sci 107:125–155
Holmberg K, Jönsson B, Kronberg B, Lindmam B (2002) Surfactants and polymers in aqueous solution, 2nd edn. Wiley, New York, pp 451–471
Marszal L (1987) HLB of nonionic surfactants: PIT and EPI methods. In: Schick MJ (ed) Surfactant science series, nonionic surfactants – physical chemistry, vol 23. Marcel Dekker Inc, New York, pp 493–547
Fernandez P, André V, Rieger J, Kühmle A (2004) Nano-emulsions formation by emulsion phase inversion. Colloids Surf A 251:53–58
Tadros T, Izquierdo P, Esquena J, Solans C (2004) Formation and stability of nanoemulsions. Adv Colloid Interface Sci 109:303–318
Burgess DJ, Sahin NO (1997) Interfacial rheological and tension properties of protein films. J Colloid Interface Sci 189:74–82
Jiao J, Rhodes DG, Burgess DJ (2002) Multiple emulsion stability: pressure balance and interfacial film strength. J Colloid Interface Sci 250:444–450
Jiao J, Burgess DJ (2003) Rheology and stability of water-in-oil-in-water multiple emulsion containing Span83 and Tween80. AAPS J 5(1):62–73
Morais JM, Rocha-Filho PA, Burgess DJ (2009) Influence of phase inversion on the formation and stability of one-step multiple emulsions. Langmuir 25(14):7954–7961
Opawale FO, Burgess DJ (1998) Influence of interfacial rheological properties of mixed emulsifier films on the stability of water-in-oil-in-water emulsions. J Pharm Pharmacol 50:965–973
Opawale FO, Burgess DJ (1998) Influence of interfacial properties of lipophilic surfactants on water-in-oil emulsion. J Colloid Interface Sci 197:142–150
Robins MM, Hibberd DJ (1998) Emulsion flocculation and creaming. In: Binks BP (ed) Modern aspects of emulsion science. Royal Society of Chemistry, Cambridge, pp 115–144
Schramm LL, Stasiuk EN, Marangoni DG (2003) Surfactants and their applications. Annu Rep Prog Chem Sect C 99:3–48
Driscoll DF, Bistrian BR, Demmelmair H, Koletzko B (2008) Pharmaceutical and clinical aspects of parenteral lipid emulsions in neonatology. Clin Nutr 27:497–503
Oussoren C, Talsma H, Zuidema J, Kadir F (2005) Biopharmaceutical principles of injectable dispersed systems. In: Burgess DJ (ed) Drug and the pharmaceutical sciences – injectable dispersed systems. Formulation, processing and performance, vol 149. Taylor & Francis, Boca Raton, pp 39–76
Sonneville-Aubrun O, Simonnet J-T, L’Alloret F (2004) Nanoemulsions: a new vehicle for skincare products. Adv Colloid Interface Sci 108–109:145–149
Date AA, Nagarsenker MS (2008) Parenteral microemulsions: an overview. Int J Pharm 355:19–30
Tije AJ, Verweij J, Loos WJ, Spareboom A (2003) Pharmacological effects of formulation vehicles implications for cancer chemotherapy. Clin Pharmacokinet 42:665–685
Söderlind E, Wollbratt M, Corswant CV (2003) The usefulness of sugar surfactants as solubilizing agents in parenteral formulations. Int J Pharm 252:61–71
Ott G, Singh M, Kazzaz J, Briones M, Soenawan E, Ugozzoli M (2002) A cationic sub-micron emulsion (MF59/DOTAP) is an effective delivery system for DNA vaccines. J Control Release 79:1–5
Florence AT, Whitehill D (1982) The formulation and stability of multiple emulsions. Int J Pharm 11:277–308
Garti N (1997) Double emulsions – scope, limitations and new achievements. Colloids Surf A 123–124:233–246
Matsumoto S (1983) Development of W/O/W – type dispersion during phase inversion of concentrated W/O emulsions. J Colloid Interface Sci 94:362–368
Carlloti ME, Gallarate M, Sapino S, Ugazio E (2005) W/O/W multiple emulsions for dermatological and cosmetic use, obtained with ethylene oxide free emulsifiers. J Dispersion Sci Technol 26(2):83–192
Nakhare S, Vyas SP (1996) Preparation and characterization of multiple emulsions based systems for controlled diclofenac sodium release. J Microencapsul 13(3):281–292
Vasudevan TV, Naser MS (2002) Some aspects of stability of multiple emulsions in personal cleansing systems. J Colloid Interface Sci 256:208–215
Yu S-C, Bochot A, Le Bas G, Chéron M, Mahuteau J, Grossiord J-L, Seiller M, Duchêne D (2003) Effect of camphor/cyclodextrin complexation on the stability of O/W/O multiple emulsions. Int J Pharm 261:1–8
Fox C (1986) An introduction to multiple emulsions. Cosmet Toiletries 101(11):101–112
Oh C, Park J-H, Shin S-I, S-G OH (2004) O/W/O multiple emulsions via one-step emulsification process. J Dispersion Sci Technol 25(1):53–62
Cole ML, Whateley TL (1997) Release rate profiles of theophylline and insulin from stable multiple w/o/w emulsions. J Control Release 49:51–58
Ceglie A, Das KP, Lindman B (1987) Effect of oil on the microscopic structure in four component cosurfactants microemulsions. Colloids Surf 28:29–40
Wennerstrom H, Soderman O, Olsson U, Lindman B (1997) Macroemulsions versus microemulsions. Colloids Surf A 123–124:13–26
Attwood D (1994) Microemulsions. In: Kreuter J (ed) Colloidal drug delivery systems. Marcel Dekker, New York, pp 31–71
Lam AC, Falk NA, Schechter RS (1987) The thermodynamics of microemulsions. J Colloid Interface Sci 120(1):30–41
He L, Wang G, Zhang Q (2003) An alternative paclitaxel microemulsion formulation: hypersensitivity evaluation and pharmacokinetic profile. Int J Pharm 250:45–50
Moreno MA, Frutos P, Ballesteros MP (2001) Lyophilized lecithin based oil–water microemulsions as a new and low toxic delivery system for amphotericin B. Pharm Res 18:344–351
Wang J-J, Sung KC, Oliver Y-PH, Chih-Hui Y, Jia-Yo F (2006) Submicron lipid emulsion as a drug delivery system for nalbuphine and its prodrugs. J Control Release 115:140–149
Floyd AG (1999) Top ten considerations in the development of parenteral emulsions. Pharm Sci Technol Today 2(4):134–143
Hansrani PK, Davis SS, Groves MJ (1983) The preparation and properties of sterile intravenous emulsions. J Parenter Sci Technol 37:145–150
Brooks BW, Richmond H (1991) Dynamics of liquid-liquid inversion using non-ionic surfactants. Colloids Surf 58:131–148
Salager JL, Marquéz L, Peña AA, Rondón M, Silva F, Tyrode E (2000) Current phenomenological know-how and modeling of emulsion inversion. Ind Eng Chem Res 39:2665–2675
Saito H, Shinoda K (1967) The solubilization of hydrocarbons in aqueous solution of nonionic surfactants. J Colloid Interface Sci 24:10
Shinoda K, Friberg SE (1986) Factors affecting the phase inversion temperature in an emulsion. Emulsions and solubilization. Wiley, New York, pp 96–123
Salager JL, Forgiarini A, Marquéz L, Peña A, Pizzino A, Rodriguez MP, González MR (2004) Using emulsion inversion in industrial process. Adv Colloid Interface Sci 259:108–109
Vaessen GEJ, Stein HN (1995) The applicability of catastrophe theory to emulsion phase inversion. J Colloid Interface Sci 176:378–387
Zerfa M, Sajjadi S, Brooks BW (2001) Phase behaviour of polymer emulsions during the phase inversion process in the presence of non-ionic surfactants. Colloids Surf A 178:41–48
Bouchama F, Van Aken GA, Autin AJE, Koper GJM (2003) On the mechanism of catastrophic phase inversion in emulsions. Colloids Surf A 231:11–17
Devani MJ, Ashfird M, Craig DQM (2005) The development and characterization of triglyceride-based “spontaneous” multiple emulsions. Int J Pharm 300:76–88
Sajjadi S, Jahanzad F, Yianneskis M, Brooks BW (2003) Phase inversion in abnormal O/W/O emulsions: effect of surfactant hydrophilic-lipophilic balance. Ind Eng Chem Res 42:3571–3577
Morais JM, Santos ODH, Nunes JRL, Zanatta CF, Rocha-Filho PA (2008) W/O/W multiple emulsion obtained by one-step emulsification method and evaluation of the involved variables. J Dispersion Sci Technol 29(1):63–69
Förster T, Von Rybinski W, Wadle A (1995) Influence of microemulsion phases on the preparation of fine-disperse emulsions. Adv Colloid Interface Sci 58:119–149
Schulman JH, Stoeckenius W, Prince LM (1959) Mechanism of formation and structure of micro emulsions by electron microscopy. J Phys Chem 63(10):1677–1680
Kim C (2000) Controlled release dosage form design. Technomic Publishing CO, Inc, Lancaster-Basel, p 301
Kydonieus AF (1980) Controlled release technologies: methods, theory, and applications, vol 1. CRC, Boca Raton
Washington C (1990) Drug release from microdisperse systems: a critical review. Int J Pharm 58:1–12
Brodin AF, Kavaliunas PR, Frank SG (1978) Prolonged drug release from multiple emulsions. Acta Pharmaceutica Suecica 15(1):111–118
Burbage AS, Davis SS (1980) The characterization of multiple emulsions using a radiotracer technique. J Pharm Pharmacol 31(6) Supplement
Laugel C, Baillet A, Youenang Piemi MP, Marty JP, Ferrier D (1998) Oil-water-oil multiple emulsion for prolonged delivery of hydrocortisone after topical application: comparison with simple emulsions. Int J Pharm 160:109–117
Klang SH, Parnas M, Benita S (1998) Emulsions as drug carriers – possibilities, limitations and future perspectives. In: Müller RH, Benita S, Böhm B (eds) Emulsions and nanosuspensions for the formulation of poorly soluble drugs. Medpharm Scientific Publishers, Stuttgart, pp 31–65
Muller RH (1991) Colloidal carriers for controlled drug delivery and targeting: Modification, characterization and in vivo distribution. Wiss. Ver.-Ges., CRS Press, Inc., Stuttgart
Owais M, Gupta CM (2005) Targeted drug delivery to macrophages in parasitic infections. Curr Drug Deliv 2:311–318
Poste G, Kirsh R (1983) Site-specific (targeted) drug delivery in cancer chemotherapy. Biotechnology 1:869–878
Greenwald RB, Choe YH, McGuire J, Conover CD (2003) Effective drug delivery by PEGylated drug conjugates. Adv Drug Deliv Rev 55:217–250
Otsuka H, Nagasaki Y, Kataoka K (2003) PEGylated nanoparticles for biological and pharmaceutical applications. Adv Drug Deliv Rev 55(3):403–419
Koster VS, Kuks PFM, Lang R, Talsma H (1996) Particle size in parenteral fat emulsions, what are the true limitations? Int J Pharm 134:235–238
Roth B, Fkelund M, Fan BG, Hagerstrand I, Nilsson-Ehie P (1996) Lipid deposition in Kupffer cells after parenteral fat nutrition in rats: a biochemical and structural study. Intensive Care Med 22:1224–1231
Schwarz C, Mehnert W, Lucks JS, Moiler RH (1994) Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization. J Control Release 30:83–96
Burnham WR, Hansrani PK, Knott CE, Cook CA, Davis SS (1983) Stability of a fat emulsion based intravenous feeding mixture. Int J Pharm 13:9–22
Washington C, Evans K (1995) Release rate measurements of model hydrophobic solutes from submicron triglyceride emulsions. J Control Release 33:383–390
Armoury N, Fessi H, Devissauget JP, Puisieux F, Benita S (1990) In vitro release kinetic pattern of indomethacin from poly (d.l-lactic) nanocapsules. J Pharm Sci 79:763–767
Friedman D, Benita S (1987) A mathematical model for drug release from o/w emulsions: Application to controlled release morphine emulsions. Drug Dev Ind Pharm 13:2067–2086
Lostritto RT, Goei L, Silvestri SL (1987) Theoretical considerations of drug release from submicron oil-in-water emulsions. J Parenter Sci Technol 41:215–219
Bhardwaj U, Burgess DJ (2010) A novel USP apparatus 4 based release testing method for dispersed systems. Int J Pharm 388:287–294
Chibambaram N, Burgess DJ (1999) A novel in vitro release method for submicron-sized dispersed systems. AAPS Pharmsci 1(3):1–9
Desai MP, Labhasetwar V, Walter E, Levy RJ, Amidon GL (1997) The mechanism of uptake of biodegradable microspheres in caco-2 cells is size dependent. Pharm Res 14:1568–1573
Chattaraj SC, Kanfer I (1995) Release of acyclovir from semi-solid dosage forms: a semi-automated procedure using a simple plexiglass flow-through cell. Int J Pharm 125:215–222
Liebenberg W, Engelbrecht E, Wessels A, Devarakonda B, Yang W, De Villiers MM (2004) A comparative study of the release of active ingredients from semisolid cosmeceuticals measured with franz, enhancer or flow-through cell diffusion apparatus. J Food Drug Anal 12(1):19–28
Food and Drug Administration FDA (2004) Criteria for safety and efficacy evaluation of oxygen therapeutics as red blood cell substitutes (Draft Guidance)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Controlled Release Society
About this chapter
Cite this chapter
Morais, J.M., Burgess, D.J. (2012). Micro- and Nanoemulsions (Controlled Release Parenteral Drug Delivery Systems). In: Wright, J., Burgess, D. (eds) Long Acting Injections and Implants. Advances in Delivery Science and Technology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-0554-2_12
Download citation
DOI: https://doi.org/10.1007/978-1-4614-0554-2_12
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4614-0553-5
Online ISBN: 978-1-4614-0554-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)